KRAS and non-small cell lung carcinoma: For example, mutations in p53 gene occur in over half of NSCLC cases, and epidermal growth factor receptor gene (EGFR) and Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations are associated with worse clinical outcome [2].